Cargando…

Comparison of multiparametric ultrasound versus multiparametric magnetic resonance imaging for diagnosis of carcinoma prostate: The CADMUS trial

Detalles Bibliográficos
Autor principal:	Tarigopula, Vivek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2022
Materias:	Uroscan
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9787433/ https://www.ncbi.nlm.nih.gov/pubmed/36568461 http://dx.doi.org/10.4103/iju.iju_221_22

Ejemplares similares

Multiparametric magnetic resonance imaging-targeted biopsies in the detection of clinically significant prostate cancer
por: Charalampos, Fragkoulis
Publicado: (2020)

Long-term follow-up results of nivolumab plus cabozantinib versus sunitinib for advanced renal cell cancer: Checkmate 9ER trial
por: Tarigopula, Vivek
Publicado: (2022)

PROMPTS Trial: Screening spinal magnetic resonance imaging in castration-resistant prostate cancer
por: Pattnaik, Soumya Shivasis
Publicado: (2023)

STHLM3-MRI study: Role of magnetic resonance imaging-targeted biopsy in prostate cancer screening
por: Gaur, Abhay S.
Publicado: (2022)

Multiparametric magnetic resonance imaging of prostate cancer
por: Hedgire, Sandeep S, et al.
Publicado: (2012)

Multiparametric magnetic resonance imaging of prostate cancer
por: Sivrioglu, Ali Kemal, et al.
Publicado: (2013)

Thulium laser versus standard transurethral resection of the prostate: A randomized prospective trial
por: Dubey, Deepak, et al.
Publicado: (2008)

Developing Strategy to Predict the Results of Prostate Multiparametric Magnetic Resonance Imaging and Reduce Unnecessary Multiparametric Magnetic Resonance Imaging Scan
por: Liu, Junxiao, et al.
Publicado: (2021)

Multiparametric Magnetic Resonance Imaging Characteristics of Prostate Tuberculosis
por: Cheng, Yue, et al.
Publicado: (2015)

Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer
por: Oppenheimer, Daniel Corey, et al.
Publicado: (2016)

Multiparametric magnetic resonance imaging of the prostate: current concepts
por: Bittencourt, Leonardo Kayat, et al.
Publicado: (2014)

The current role of prostate multiparametric magnetic resonance imaging
por: Rouviere, Olivier, et al.
Publicado: (2019)

PROFOUND trial –a new era in targeted therapeutics for prostate carcinoma
por: Tosh, Jyoti Mohan
Publicado: (2022)

Apalutamide: A novel therapy for non metastatic castration-resistant carcinoma prostate
por: Jayasimha, Sudhindra
Publicado: (2018)

Comparing outcomes between neoadjuvant hormonal therapy followed by prostatectomy versus upfront prostatectomy in high-risk prostate cancer: The road ahead
por: Bhargava, Priyank
Publicado: (2023)

Multiparametric magnetic resonance imaging of prostate: the evolution of a technique
por: Muglia, Valdair Francisco
Publicado: (2014)

Multiparametric magnetic resonance imaging findings of prostatic pure leiomyomas
por: Mussi, Thais Caldara, et al.
Publicado: (2016)

Multiparametric Magnetic Resonance Imaging for Active Surveillance of Prostate Cancer
por: An, Julie Y., et al.
Publicado: (2017)

Multiparametric magnetic resonance imaging of the prostate—a basic tutorial
por: Cabarrus, Miguel C., et al.
Publicado: (2017)

Multiparametric Magnetic Resonance Imaging Grades the Aggressiveness of Prostate Cancer
por: Morote, Juan, et al.
Publicado: (2022)

Multiparametric ultrasound of prostate: role in prostate cancer diagnosis
por: Kaneko, Masatomo, et al.
Publicado: (2022)

Defining the role of antioxidants in the prevention of prostate cancer
por: Pathak, Hemant R., et al.
Publicado: (2009)

Lutetium-177 prostate-specific membrane antigen-617 theranostics: New therapeutic hope in metastatic castrate-resistant prostate cancer?
por: Ranjan, Satish Kumar
Publicado: (2020)

Virtual versus real cystoscopy
por: Yadav, Rajiv, et al.
Publicado: (2007)

Transurethral ethanol ablation for symptomatic benign prostatic hyperplasia
por: Gautam, Gagan, et al.
Publicado: (2007)

Endocrine treatment in advanced prostate cancer: When to start?
por: Choudhrie, A. V., et al.
Publicado: (2009)

The current role of Active Surveillance in early prostate cancer
por: Shrinivas, R. P., et al.
Publicado: (2009)

Diagnosis of clinically significant prostate cancer after negative multiparametric magnetic resonance imaging
por: Zattoni, Fabio, et al.
Publicado: (2022)

Prostate volume measurement by multiparametric magnetic resonance and transrectal ultrasound: comparison with surgical specimen weight
por: Martins, Tatiana, et al.
Publicado: (2020)

Comparison of Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging in Patients with Prostate Biopsy Indications
por: Altay, Mehmet Sefa, et al.
Publicado: (2022)

Neoadjuvant androgen suppression in patients treated with high-intensity focused ultrasound therapy
por: Khochikar, Makarand V.
Publicado: (2007)

Safety and efficacy of active surveillance in patients with localized prostate cancer
por: Mavuduru, Ravimohan, et al.
Publicado: (2008)

Prostate cancer treatment does not increase the risk of cardiovascular events
por: Khochikar, Makarand V.
Publicado: (2007)

Relugolix – The novel oral androgen deprivation therapy for prostate cancer
por: Jena, Rahul
Publicado: (2020)

Rezvilutamide for metastatic castration-sensitive prostate cancer: CHART trial
por: Singh, Kirti
Publicado: (2023)

A novel approach to management of nocturia in patients with benign prostatic hyperplasia
por: Sengottayan, Vengetesh K., et al.
Publicado: (2009)

Is incidence of prostate cancer higher in patients with end stage renal disease?
por: Khochikar, Makarand V.
Publicado: (2007)

Quantification of hepatocellular carcinoma heterogeneity with multiparametric magnetic resonance imaging
por: Hectors, Stefanie J., et al.
Publicado: (2017)

Docetaxel, abiraterone, enzalutamide, apalutamide in patients with metastatic hormone-sensitive prostate cancer
por: Talwar, Harkirat Singh
Publicado: (2021)

Triple therapy for metastatic castration sensitive prostate cancer: PEACE-1 trial
por: Singh, Kirti
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_62tpa2kakcuonkah65jrtk5q57